Amgen Announces Deal With Glaxo - New York Times

RTT News

Amgen Announces Deal With Glaxo New York Times By REUTERS NEW YORK (Reuters) - Amgen reported much better-than-expected second-quarter earnings, helped by a rebound in sales of its rheumatoid arthritis ... Amgen quarterly profit tops StreetReuters Amgen 2Q Profits Rise 40%; Boosts 2009 View >AMGNWall Street Journal GSK to co-market Amgen's osteoporosis drug in EuropePharmafocus Wall Street Journal all 217 news articles »

BioScrip expansion to offer injectable medicine - Columbus Dispatch

BioScrip expansion to offer injectable medicine Columbus Dispatch Some of the medications prevent flare-ups, or an escalation to a more severe stage, he added. For rheumatoid arthritis, many of the most effective ...

FDA OKs new use for Lilly osteoporosis drug Forteo - Forbes

FDA OKs new use for Lilly osteoporosis drug Forteo Forbes ... drug to be used as a treatment for patients taking medications for inflammatory conditions like rheumatoid arthritis and obstructive pulmonary disease. ... Forteo Approved for Drug-Related OsteoporosisAtlanta Journal Constitution FDA approved new indication for teriparatide to treat osteoporosisEndocrine Today FDA Approves Expanded Use of Lilly's FORTEO(R) [teriparatide (rDNA ...PR Newswire (press release) all 58 news articles »

The Next Blockbuster Drugs - Newsweek

The Next Blockbuster Drugs Newsweek The furthest along of the two early candidates is ARRY-162, which is now in a Phase II trial in 200 patients with rheumatoid arthritis. ... and more »